Research Article
Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy
Table 6
Results of molecular docking.
| | Core component | Target | PDB ID | Binding energy (kcal/mol) |
| | | VEGFA | 4QAF | −5.8 | | IL6 | 1ALU | −5.4 | | Quercetin | TNF | 6OP0 | −10 | | AKT1 | 4GV1 | −7.9 | | TP53 | 5O1E | −8.2 | | VEGFA | 4QAF | −9.4 | | IL6 | 1ALU | −5.5 | | Formononetin | TNF | 6OP0 | −9.2 | | AKT1 | 4GV1 | −8.4 | | TP53 | 5O1E | −7.6 | | VEGFA | 4QAF | −6.1 | | IL6 | 1ALU | −5.7 | | Kaempferol | TNF | 6OP0 | −10.1 | | AKT1 | 4GV1 | −7.8 | | TP53 | 5O1E | −7.0 | | VEGFA | 4QAF | −8.1 | | IL6 | 1ALU | −5.2 | | Isorhamnetin | TNF | 6OP0 | −8.2 | | AKT1 | 4GV1 | −8.2 | | TP53 | 5O1E | −8.0 | | VEGFA | 4QAF | −7.7 | | IL6 | 1ALU | −5.1 | | Beta-Sitosterol | TNF | 6OP0 | −9.7 | | AKT1 | 4GV1 | −9.3 | | TP53 | 5O1E | −6.1 |
|
|